Two leukemia drugs could be used against treatment-resistant lung cancer, with a clinical trial expected to launch in Toronto and Zagreb, Croatia, later this year to evaluate one of them. The journal iNature Chemical Biology/i published the findings.
"Drug resistance is a big problem for lung cancer patients," says Stagljar. "Our new technology allows us to find molecules that could be used against cancers for which no other treatment options are available."
The researchers identified ...
Two leukemia drugs could be used against treatment-resistant lung cancer, with a clinical trial expected to launch in Toronto and Zagreb, Croatia, later this year to evaluate one of them. The journal iNature Chemical Biology/i published the findings.
"Drug resistance is a big problem for lung cancer patients," says Stagljar. "Our new technology allows us to find molecules that could be used against cancers for which no other treatment options are available."
The researchers identified ...